Metrics as of 10/16/2026, 05:20 AM (Berlin time), refresh in progress.
Definitive Healthcare Corp.
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from…
1D
+1.1%
1W
+3.1%
1M
-0.4%
6M
-5.1%
YTD
-65.3%
1Y
-66.7%
2Y
-77.5%
5Y
-97.6%
10Y
–
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~105% stronger price swings than usual
PRICE TARGET LOW
US$1.00
CONSENSUS
US$1.20
MEDIAN
US$1.10
PRICE TARGET HIGH
US$1.50
0
STRONG BUY
3
BUY
9
HOLD
3
SELL
0
STRONG SELL
15
TOTAL · Hold
As of: 11/08/2026
P/E
-0.62
P/B
0.73
EV/EBITDA
-0.6
RETURN ON EQUITY
-3.7%
NET MARGIN
-9.8%
DEBT/EQUITY
1.15
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
29.4%
FLOAT SHARES
31,430,660
AVG. DAILY VOLUME (30D)
697,378
Heller Casey
Paris Jonathan
Heller Casey
Krantz Jason Ronald
Heller Casey
Definitive Healthcare Corp. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Clay Ritchey, the company employs around 682 people.
The IPO was on 15/09/2021; the stock trades on NASDAQ under the ticker DH.
15 analysts rate the stock, the consensus is Hold (as of 11/08/2026).
The average price target is US$1.20, ranging from US$1.00 to US$1.50, with a median of US$1.10.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 105% stronger than usual.
No, Definitive Healthcare currently does not pay a dividend.
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
Clicking "Analyze stock" lets five strategies assess Definitive Healthcare against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.